主动式经皮骨传导听力装置的临床结局:一项回顾性研究
该研究回顾性分析了60例患者共67枚Osia 2装置的植入情况,平均手术时间53.9分钟,纯音平均增益41.2 dB,6 kHz和8 kHz增益分别为35.42 dB和40.67 dB,噪声和安静条件下言语识别阈值及言语识别率均显著改善,全因不良事件/并发症率为10.4%。
要点
- Osia 2装置植入后高频增益良好,6 kHz和8 kHz增益分别为35.42 dB和40.67 dB。
- 噪声和安静条件下言语识别阈值及言语识别率均显著改善。
- 全因不良事件/并发症率为10.4%,最常见为感染(4.5%)和术后疼痛控制不良(3.0%)。
核心结论
- 在本系列中,使用Osia 2装置取得了良好的听力 outcomes,尤其在高频增益方面。
- 并发症发生率低。
- 据作者所知,这是迄今报告Osia 2结局的最大规模研究。
研究设计与样本
- 回顾性病例系列。
- 单中心三级机构经验。
- 纳入2019年至今由资深作者植入Osia 2的患者,共60例患者和67枚植入体。
主要发现
- 患者中位年龄51岁(范围11-92岁)。
- 55%的患者为混合性听力损失,30%为单侧聋,15%为传导性听力损失。
- 平均手术时间53.9分钟;仅4.5%的患者需要骨打磨,3.0%需要组织减薄。
- 与未助听条件相比,纯音平均增益为41.2 dB,6 kHz和8 kHz平均增益分别为35.42 dB和40.67 dB。
- 噪声和安静条件下言语识别阈值及言语识别率平均改善均显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to review patient demographics, indications, intraoperative findings, complications/adverse events, and audiological outcomes related to the implantation of the Osia 2 device. STUDY DESIGN: Retrospective case series. SETTING: Single tertiary institutional experience. METHODS: Patients who had undergone Osia 2 implantation by the senior author were identified from 2019 to present. Information was extracted from patient charts concerning patient demographics, indications for implantation, surgical findings, audiological outcomes, and adverse events. RESULTS: Sixty patients and 67 implants were included. The median age was 51 years (R: 11-92). Fifty-five percent of patients had mixed hearing loss (HL), 30% had single-sided deafness, and 15% had conductive HL. The mean operative time was 53.9 minutes. Only 4.5% of patients required bone polishing, and 3.0% required tissue thinning. The mean pure-tone averages 4 gain from unaided conditions was 41.2 dB. Mean gain at 6 and 8 kHz from unaided conditions was 35.42 and 40.67 dB, respectively. Mean improvement in speech recognition threshold and word recognition score was significant in noise and quiet conditions. The all-cause adverse event/complication rate in our series was 10.4%. The most common complications were infections (4.5%) and poorly controlled postoperative pain (3.0%). Hematomas occurred in 1.5% of patients. Reoperation was required in 4 patients; explant in 1. CONCLUSION: Use of the Osia 2 device in our series has resulted in good hearing outcomes, particularly in terms of high frequency gain. Complication rates were low. To our knowledge, this is the largest study to date reporting on Osia 2 outcomes.
引用
- Jukic A, Cismas M, Flores N, et al. Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study. Otolaryngol Head Neck Surg. 2024. PMID: 38667828. doi:10.1002/ohn.791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。